FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Advertise here The Food and Drug Administration on Thursday accredited the Alzheimer’s remedy Leqembi, a pivotal resolution that’s anticipated to increase entry to the costly drug for older Americans. Medicare…